Outcomes

The available evidence for alpha-lipoic acid outcomes is limited in scope and clinical detail based on current literature searches. The following measurable results have been reported:

Weight Management

A systematic review and meta-analysis examined alpha-lipoic acid among other nutraceuticals for antipsychotic-induced weight gain in schizophrenia spectrum disorders, though specific outcome measures and effect sizes for alpha-lipoic acid alone are not detailed in the available abstracts.

Hepatoprotective Effects

One study evaluated alpha-lipoic acid co-loaded with glycyrrhetinic acid in nanophytosomes as a strategy to mitigate cisplatin-induced liver damage. However, the specific biomarker changes or protective outcomes achieved are not quantified in the available abstract.

Ototoxicity Prevention

A completed Phase 2/3 clinical trial (NCT00477607) investigated alpha-lipoic acid for preventing hearing loss in cancer patients receiving cisplatin treatment. The trial status indicates completion, but outcome results are not available in the current evidence.

Antioxidant Activity

Studies have examined alpha-lipoic acid's antioxidant properties in various contexts, including ovarian tissue cryopreservation and acute supplementation effects related to race and aging. Specific biomarker changes or clinical improvements are not quantified in the available abstracts.

Evidence Limitations

The strength of evidence is notably limited by:

Lack of specific outcome measures and effect sizes in available abstracts
Missing results from completed clinical trials
Primarily preclinical or formulation studies rather than clinical effectiveness data
No clear quantification of symptom improvement or biomarker changes

Disclaimer: This summary is for informational purposes only and should not be used as a substitute for professional medical advice. Consult healthcare providers before using alpha-lipoic acid for any medical condition.

More comprehensive clinical outcome data would be needed to draw definitive conclusions about alpha-lipoic acid's therapeutic effectiveness across different conditions.

Alpha-Lipoic Acid

Member access required